Wagner Bowman Management Corp acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,310 shares of the company’s stock, valued at approximately $222,000.

Other large investors also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Henry Schein during the fourth quarter valued at approximately $139,100,000. Renaissance Technologies LLC acquired a new stake in shares of Henry Schein during the fourth quarter valued at approximately $71,911,000. Congress Asset Management Co. MA acquired a new stake in shares of Henry Schein during the fourth quarter valued at approximately $53,903,000. Champlain Investment Partners LLC boosted its stake in shares of Henry Schein by 198.6% in the fourth quarter. Champlain Investment Partners LLC now owns 307,875 shares of the company’s stock valued at $46,708,000 after buying an additional 204,760 shares during the period. Finally, Mackenzie Financial Corp boosted its stake in shares of Henry Schein by 17.4% in the third quarter. Mackenzie Financial Corp now owns 1,367,762 shares of the company’s stock valued at $222,918,000 after buying an additional 203,188 shares during the period. 90.91% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded down 0.76% on Friday, reaching $168.11. 298,116 shares of the company were exchanged. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $183.00. The firm has a market capitalization of $13.31 billion, a PE ratio of 27.16 and a beta of 1.02. The company’s 50 day moving average is $170.29 and its 200 day moving average is $160.58.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 21st. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.03. The firm earned $3.12 billion during the quarter, compared to the consensus estimate of $3.08 billion. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The company’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $1.67 earnings per share. Analysts forecast that Henry Schein, Inc. will post $7.25 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Wagner Bowman Management Corp Invests $222,000 in Henry Schein, Inc. (HSIC)” was first posted by Financial Market News and is the sole property of of Financial Market News. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at http://www.financial-market-news.com/wagner-bowman-management-corp-invests-222000-in-henry-schein-inc-hsic/1406284/.

Several brokerages have commented on HSIC. Craig Hallum began coverage on shares of Henry Schein in a research report on Tuesday, April 11th. They set a “hold” rating on the stock. Deutsche Bank AG began coverage on shares of Henry Schein in a research report on Wednesday, March 15th. They set a “hold” rating and a $174.00 price target on the stock. Jefferies Group LLC reissued a “hold” rating and set a $165.00 price target on shares of Henry Schein in a research report on Tuesday, February 28th. Leerink Swann set a $183.00 price target on shares of Henry Schein and gave the stock a “hold” rating in a research report on Wednesday, February 22nd. Finally, Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, February 23rd. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Henry Schein presently has an average rating of “Hold” and an average price target of $180.84.

In related news, Director Donald J. Kabat sold 4,334 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average price of $173.62, for a total transaction of $752,469.08. Following the completion of the transaction, the director now owns 10,729 shares of the company’s stock, valued at $1,862,768.98. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 1,103 shares of the business’s stock in a transaction that occurred on Wednesday, March 8th. The shares were sold at an average price of $171.51, for a total transaction of $189,175.53. Following the transaction, the director now directly owns 13,872 shares of the company’s stock, valued at approximately $2,379,186.72. The disclosure for this sale can be found here. Insiders sold 67,670 shares of company stock valued at $11,650,932 in the last quarter. Corporate insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

5 Day Chart for NASDAQ:HSIC

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.